Name: UMIN ID:
Unique ID issued by UMIN | UMIN000008611 |
---|---|
Receipt number | R000010124 |
Scientific Title | A single-center open-label parallel-group study on the efficacy and the safety of survivin-2B peptide vaccine therapy for patients with advanced or recurrent digestive organ cancer, for which there is no effective treatment. |
Date of disclosure of the study information | 2012/08/03 |
Last modified on | 2014/04/14 15:31:53 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2012/08/03 20:53:37 | ||
2 | Update | 2012/08/27 14:24:18 | Acronym Acronym |
|
3 | Update | 2012/09/06 13:45:03 | Recruitment status |
|
4 | Update | 2013/02/14 17:31:29 | Last follow-up date |
|
5 | Update | 2014/04/14 11:53:00 | Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded Publication of results |
|
6 | Update | 2014/04/14 15:31:53 | Recruitment status |